Bacteria flying under the radar: Linking a bacterial infection to colon carcinogenesis

Infectious Agents and Cancer

Volumn 9, Issue 1, 2014, Pages

  Keenan, Jacqueline I ^a   Frizelle, Frank A ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Bacterial persistence; Bacteroides fragilis; Colorectal cancer; Host response

Indexed keywords

ARTICLE; BACTERIAL INFECTION; BACTERIAL PERSISTENCE; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIAL STRAIN; BACTEROIDES FRAGILIS; BACTEROIDES INFECTION; CANCER RISK; COLON CARCINOGENESIS; COLORECTAL CANCER; DISEASE ASSOCIATION; HELICOBACTER PYLORI; HUMAN; INTESTINE FLORA;

EID: 84907447822     PISSN: None     EISSN: 17509378     Source Type: Journal    
DOI: 10.1186/1750-9378-9-31     Document Type: Article

References (21)

1. Helicobacter pylori persistence: biology and disease. Blaser MJ, Atherton JC, J Clin Invest 2004 113 321 333 10.1172/JCI20925 14755326
2. Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk. Blaser MJ, Chyou PH, Nomura A, Cancer Res 1995 55 562 565 7834625
3. Helicobacter pylori cytotoxin-associated genotype and gastric precancerous lesions. Plummer M, van Doorn LJ, Franceschi S, Kleter B, Canzian F, Vivas J, Lopez G, Colin D, Munoz N, Kato I, J Natl Cancer Inst 2007 99 1328 1334 10.1093/jnci/djm120 17728213
4. Molecular and cellular mechanisms involved in Helicobacter pylori-induced inflammation and oxidative stress. Naito Y, Yoshikawa T, Free Radic Biol Med 2002 33 323 336 10.1016/S0891-5849(02)00868-7 12126754
5. Outer membrane vesicles enhance the carcinogenic potential of Helicobacter pylori. Chitcholtan K, Hampton MB, Keenan JI, Carcinogenesis 2008 29 2400 2405 10.1093/carcin/bgn218 18784355
6. Cancer-related inflammation. Mantovani A, Allavena P, Sica A, Balkwill F, Nature 2008 454 36 444
7. Bacteroides fragilis enterotoxin induces intestinal epithelial cell secretion of interleukin-8 through mitogen-activated protein kinases and a tyrosine kinase-regulated nuclear factor-kappaB pathway. Wu S, Powell J, Mathioudakis N, Kane S, Fernandez E, Sears CL, Infect Immun 2004 72 5832 5839 10.1128/IAI.72.10.5832-5839.2004 15385484
8. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Wu S, Rhee KJ, Albesiano E, Rabizadeh S, Wu X, Yen HR, Huso DL, Brancati FL, Wick E, McAllister F, Housseau F, Pardoll DM, Sears CL, Nat Med 2009 15 1016 1022 10.1038/nm.2015 19701202
9. The Bacteroides fragilis toxin binds to a specific intestinal epithelial cell receptor. Wu S, Shin J, Zhang G, Cohen M, Franco A, Sears CL, Infect Immun 2006 74 5382 5390 10.1128/IAI.00060-06 16926433
10. Bacteroides fragilis enterotoxin cleaves the zonula adherens protein, E-cadherin. Wu S, Lim KC, Huang J, Saidi RF, Sears CL, Proc Natl Acad Sci U S A 1998 95 14979 14984 10.1073/pnas.95.25.14979 9844001
11. Bacteroides fragilis enterotoxin induces c-Myc expression and cellular proliferation. Wu S, Morin PJ, Maouyo D, Sears CL, Gastroenterology 2003 124 392 400 10.1053/gast.2003.50047 12557145
12. Induction of persistent colitis by a human commensal, enterotoxigenic Bacteroides fragilis, in wild-type C57BL/6 mice. Rhee KJ, Wu S, Wu X, Huso DL, Karim B, Franco AA, Rabizadeh S, Golub JE, Mathews LE, Shin J, Sartor RB, Golenbock D, Hamad AR, Gan CM, Housseau F, Sears CL, Infect Immun 2009 77 1708 1718 10.1128/IAI.00814-08 19188353
13. Helicobacter pylori CagA interacts with E-cadherin and deregulates the beta-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Murata-Kamiya N, Kurashima Y, Teishikata Y, Yamahashi Y, Saito Y, Higashi H, Aburatani H, Akiyama T, Peek RM Jr, Azuma T, Hatakeyama M, Oncogene 2007 26 4617 4626 10.1038/sj.onc.1210251 17237808
14. A possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer. Toprak NU, Yagci A, Gulluoglu BM, Akin ML, Demirkalem P, Celenk T, Soyletir G, Clin Microbiol Infect 2006 12 782 786 16842574
15. Chemical structure and biologic activity of bacterial and synthetic lipid A. Rietschel ET, Brade L, Brandenburg K, Flad HD, de Jong-Leuveninck J, Kawahara K, Lindner B, Loppnow H, Lüderitz T, Schade U, Seydel U, Zidorczyk S, Tacken A, Zähringer U, Brade H, Rev Infect Dis 1987 9 Suppl 5 527 S536 3317748
16. The evolution of vertebrate Toll-like receptors. Roach JC, Glusman G, Rowen L, Kaur A, Purcell MK, Smith KD, Hood LE, Aderem A, Proc Natl Acad Sci U S A 2005 102 9577 9582 10.1073/pnas.0502272102 15976025
17. Compositional analysis of Helicobacter pylori rough-form lipopolysaccharides. Moran AP, Helander IM, Kosunen TU, J Bacteriol 1992 174 1370 1377 1735724
18. Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-kappa B activation and chemokine expression by epithelial cells. Smith MF Jr, Mitchell A, Li G, Ding S, Fitzmaurice AM, Ryan K, Crowe S, Goldberg JB, J Biol Chem 2003 278 32552 32560 10.1074/jbc.M305536200 12807870
19. Structural characterization of the lipid A component of Bacteroides fragilis strain NCTC 9343 lipopolysaccharide. Weintraub A, Zahringer U, Wollenweber HW, Seydel U, Rietschel ET, Eur J Biochem 1989 183 425 431 10.1111/j.1432-1033.1989.tb14945.x 2759091
20. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Round JL, Lee SM, Li J, Tran G, Jabri B, Chatila TA, Mazmanian SK, Science 2011 332 974 977 10.1126/science.1206095 21512004
21. The equilibria that allow bacterial persistence in human hosts. Blaser MJ, Kirschner D, Nature 2007 449 843 849 10.1038/nature06198 17943121